Massachusetts · Joint · Joint Committee on Health Care Financing
Health Care Resources & Market Oversight; Pharmaceutical Access, Cost & Transparency
Completed
- Date
- Monday, June 2, 2025
- Time
- 11:00 AM ET
- Committee
- Joint Committee on Health Care Financing
- Location
- Gardner Auditorium, Boston
Bills on the agenda
H 1353·In Committee
Resolve establishing a report to analyze long hospital stays
H 1355·In Committee
An Act strengthening oversight of health care facility spending
H 1356·In Committee
An Act relative to transparency of hospital and health system finances
H 1357·In Committee
An Act relative to insurer responsibility to the operating budgets of health care oversight entities
H 1361·In Committee
An Act to address health care costs through the cost benchmark and rate review processes
H 1372·In Committee
An Act to improve health care cost accountability
H 1376·In Committee
An Act relative to the operating budgets of health care oversight agencies
H 1384·In Committee
An Act updating the health care cost growth benchmark and associated market oversight activities
H 1385·In Committee
An Act expanding the moral obligation bond program to acute care hospitals
H 1397·In Committee
An Act addressing unfair business practices in health care
H 1398·In Committee
An Act relative to hospital profit and fairness
H 1408·Reported by Committee
An Act making technical changes to the Betsy Lehman Center for patient safety and medical error reduction enabling statute
H 1419·Reported by Committee
An Act relative to pharmacy deserts
H 4062·In Committee
An Act relative to essential services
S 840·Failed
An Act relative to insurer responsibility to the operating budgets of health care oversight entities
S 843·Reported by Committee
An Act making technical changes to the Betsy Lehman Center for patient safety and medical error reduction enabling statute
S 851·In Committee
An Act addressing unfair practices of private equity in health care
S 858·Reported by Committee
Resolve relative to pharmacy deserts
S 864·Failed
An Act limiting excessive growth in the operating budgets of health care oversight agencies
S 865·Failed
An Act expanding the moral obligation bond program to acute care hospitals
S 868·Reported by Committee
An Act enhancing health care market oversight and pharmaceutical access
S 873·Failed
An Act relative to hospital closures and health planning
S 875·In Committee
An Act to promote transparency in prescription drug prices
S 884·Failed
An Act to define modest meals and refreshments in prescriber education settings
S 885·Failed
An Act relative to premium impact statements
S 890·Failed
An Act to study the prevalence and cause of long term acute hospital stays
S 892·Failed
An Act to alleviate skyrocketing consumer health care costs
S 893·Failed
An Act to ensure timely health care cost reporting and protecting not-for-profit patient care
S 895·In Committee
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
S 896·Failed
An Act to prohibit inappropriate use of the health care cost growth benchmark
S 897·Failed
An Act relative to hospital price transparency
S 898·Failed
An Act relative to patient centered access to behavioral health services in accountable care organizations
S 899·Failed
An Act relative to hospital profit and fairness
S 904·In Committee
An Act to strengthen health spending accountability processes within the health policy commission and the center for health information and analysis
S 905·Failed
An Act to improve health care cost accountability
S 909·Reported by Committee
An Act empowering patients and entrepreneurs with real transparency on cost
S 911·Failed
An Act to strengthen the management of the health care connector
S 916·Failed
An Act to enhance analysis of state health mandates and costs
Never miss a hearing
Get alerts when hearings are scheduled on the bills you follow in the Massachusetts legislature, plus AI summaries and predictions.
Sign up free